Trauma Implants Market By Product (Screws, Plates, Interlocking Nails, Bioabsorbable Fixators, Others), By Material Type (Metallic Biomaterials, Bioabsorbable material), By End User (Hospitals, Orthopedic Centers, Others): Global Opportunity Analysis and

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,840	293 Pages	Allied Market Research	October, 2022	ALMR17651891

Best Price Guarantee
Price	from $3,840
Length	293 Pages
Publisher	Allied Market Research
Published Date	October, 2022
SKU	ALMR17651891

Trauma Implants Market By Product (Screws, Plates, Interlocking Nails, Bioabsorbable Fixators, Others), By Material Type (Metallic Biomaterials, Bioabsorbable material), By End User (Hospitals, Orthopedic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Trauma implants, also called as osteosynthetic implants, are the medical devices intended for repairing bone fractures and extremity joint replacement. They help to facilitate movement of joints and reduce the pain related to joint mobility. They include screw, pins, interlocking nails, and bioabsorbable fixators. These products are manufactured using metallic and biodegradable materials used in surgical implantation.

The growth of global trauma implants market is majorly driven by alarming increase in prevalence of osteoporosis conditions and surge in surgeries performed for traumatic injuries. Furthermore, factors such as rise in prevalence of road traffic accidents, technological advancement in implants, and increase in number of orthopedic centers offering trauma implant surgeries contribute toward the market growth. However, stringent government regulations for product approval restrains the growth of the market. Furthermore, high cost of surgeries and risk of infections due to metallic implants hinders growth of the market. In addition, side effects associated with surgeries such as implant failure is the major factor that negatively impact the growth of the market.

The trauma implants market is segmented into product, material type, end user, and region. By product, the market is categorized into screws, plates, interlocking nails, bioabsorbable fixators, and others. By material type, the market is classified into metallic biomaterials and bioabsorbable materials. On the basis of end user, the market is segregated into hospitals, orthopedic centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global trauma implants market are B.Braun Melsungen Ag, Bioreted Ltd, Colsin Medical Llc (Acumed), Conformis Inc., Globus Medical Inc., Johnson and Johnson (Depuy Synthes), Medtronic Plc, Orthofix Medical, Inc., Siora Surgicals Pvt.Ltd, Smith and Nephew Plc, Stryker Corporation, and Zimmer Biomet Holdings, Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the trauma implants market analysis from 2021 to 2031 to identify the prevailing trauma implants market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the trauma implants market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global trauma implants market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Screws
Plates
Interlocking Nails
Bioabsorbable Fixators
Others

By Material Type

Metallic Biomaterials
type
Stainless Steel
Titanium
Others
Bioabsorbable material

By End User

Hospitals
Orthopedic Centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest Of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest Of LAMEA

Key Market Players

Conformis
Globus Medical Inc.
Johnson & Johnson (Depuy Synthes)
B. Braun Melsungen Ag
Bioretec Ltd,
Colson Medical Llc (Acumed)
Medtronic Plc,
Orthofix Medical, Inc
Siora Surgicals Pvt. Ltd.
Smith & Nephew plc
Stryker Corporations
Zimmer Biomet Holdings

Please Note: It will take 7-10 business days to complete the report upon order confirmation.

CHAPTER 1:INTRODUCTION: 1.1.Report description; 1.2.Key market segments; 1.3.Key benefits to the stakeholders; 1.4.Research Methodology; 1.4.1.Secondary research; 1.4.2.Primary research; 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY: 2.1.Key findings of the study; 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW: 3.1.Market definition and scope; 3.2.Key findings; 3.2.1.Top investment pockets; 3.3.Porter’s five forces analysis; 3.4.Top player positioning; 3.5.Market dynamics; 3.5.1.Drivers; 3.5.2.Restraints; 3.5.3.Opportunities; 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: TRAUMA IMPLANTS MARKET, BY PRODUCT: 4.1 Overview; 4.1.1 Market size and forecast; 4.2 Screws; 4.2.1 Key market trends, growth factors and opportunities; 4.2.2 Market size and forecast, by region; 4.2.3 Market analysis by country; 4.3 Plates; 4.3.1 Key market trends, growth factors and opportunities; 4.3.2 Market size and forecast, by region; 4.3.3 Market analysis by country; 4.4 Interlocking Nails; 4.4.1 Key market trends, growth factors and opportunities; 4.4.2 Market size and forecast, by region; 4.4.3 Market analysis by country; 4.5 Bioabsorbable Fixators; 4.5.1 Key market trends, growth factors and opportunities; 4.5.2 Market size and forecast, by region; 4.5.3 Market analysis by country; 4.6 Others; 4.6.1 Key market trends, growth factors and opportunities; 4.6.2 Market size and forecast, by region; 4.6.3 Market analysis by country
CHAPTER 5: TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE: 5.1 Overview; 5.1.1 Market size and forecast; 5.2 Metallic Biomaterials; 5.2.1 Key market trends, growth factors and opportunities; 5.2.2 Market size and forecast, by region; 5.2.3 Market analysis by country; 5.2.4 Metallic Biomaterials Trauma Implants Market by type; 5.2.4.1 Stainless Steel Market size and forecast, by region; 5.2.4.2 Titanium Market size and forecast, by region; 5.2.4.3 Others Market size and forecast, by region; 5.3 Bioabsorbable material; 5.3.1 Key market trends, growth factors and opportunities; 5.3.2 Market size and forecast, by region; 5.3.3 Market analysis by country
CHAPTER 6: TRAUMA IMPLANTS MARKET, BY END USER: 6.1 Overview; 6.1.1 Market size and forecast; 6.2 Hospitals; 6.2.1 Key market trends, growth factors and opportunities; 6.2.2 Market size and forecast, by region; 6.2.3 Market analysis by country; 6.3 Orthopedic Centers; 6.3.1 Key market trends, growth factors and opportunities; 6.3.2 Market size and forecast, by region; 6.3.3 Market analysis by country; 6.4 Others; 6.4.1 Key market trends, growth factors and opportunities; 6.4.2 Market size and forecast, by region; 6.4.3 Market analysis by country
CHAPTER 7: TRAUMA IMPLANTS MARKET, BY REGION: 7.1 Overview; 7.1.1 Market size and forecast; 7.2 North America; 7.2.1 Key trends and opportunities; 7.2.2 North America Market size and forecast, by Product; 7.2.3 North America Market size and forecast, by Material Type; 7.2.3.1 North America Metallic Biomaterials Trauma Implants Market by type; 7.2.4 North America Market size and forecast, by End User; 7.2.5 North America Market size and forecast, by country; 7.2.5.1 U.S.; 7.2.5.1.1 Market size and forecast, by Product; 7.2.5.1.2 Market size and forecast, by Material Type; 7.2.5.1.3 Market size and forecast, by End User; 7.2.5.2 Canada; 7.2.5.2.1 Market size and forecast, by Product; 7.2.5.2.2 Market size and forecast, by Material Type; 7.2.5.2.3 Market size and forecast, by End User; 7.2.5.3 Mexico; 7.2.5.3.1 Market size and forecast, by Product; 7.2.5.3.2 Market size and forecast, by Material Type; 7.2.5.3.3 Market size and forecast, by End User; 7.3 Europe; 7.3.1 Key trends and opportunities; 7.3.2 Europe Market size and forecast, by Product; 7.3.3 Europe Market size and forecast, by Material Type; 7.3.3.1 Europe Metallic Biomaterials Trauma Implants Market by type; 7.3.4 Europe Market size and forecast, by End User; 7.3.5 Europe Market size and forecast, by country; 7.3.5.1 Germany; 7.3.5.1.1 Market size and forecast, by Product; 7.3.5.1.2 Market size and forecast, by Material Type; 7.3.5.1.3 Market size and forecast, by End User; 7.3.5.2 France; 7.3.5.2.1 Market size and forecast, by Product; 7.3.5.2.2 Market size and forecast, by Material Type; 7.3.5.2.3 Market size and forecast, by End User; 7.3.5.3 UK; 7.3.5.3.1 Market size and forecast, by Product; 7.3.5.3.2 Market size and forecast, by Material Type; 7.3.5.3.3 Market size and forecast, by End User; 7.3.5.4 Italy; 7.3.5.4.1 Market size and forecast, by Product; 7.3.5.4.2 Market size and forecast, by Material Type; 7.3.5.4.3 Market size and forecast, by End User; 7.3.5.5 Spain; 7.3.5.5.1 Market size and forecast, by Product; 7.3.5.5.2 Market size and forecast, by Material Type; 7.3.5.5.3 Market size and forecast, by End User; 7.3.5.6 Rest of Europe; 7.3.5.6.1 Market size and forecast, by Product; 7.3.5.6.2 Market size and forecast, by Material Type; 7.3.5.6.3 Market size and forecast, by End User; 7.4 Asia-Pacific; 7.4.1 Key trends and opportunities; 7.4.2 Asia-Pacific Market size and forecast, by Product; 7.4.3 Asia-Pacific Market size and forecast, by Material Type; 7.4.3.1 Asia-Pacific Metallic Biomaterials Trauma Implants Market by type; 7.4.4 Asia-Pacific Market size and forecast, by End User; 7.4.5 Asia-Pacific Market size and forecast, by country; 7.4.5.1 Japan; 7.4.5.1.1 Market size and forecast, by Product; 7.4.5.1.2 Market size and forecast, by Material Type; 7.4.5.1.3 Market size and forecast, by End User; 7.4.5.2 China; 7.4.5.2.1 Market size and forecast, by Product; 7.4.5.2.2 Market size and forecast, by Material Type; 7.4.5.2.3 Market size and forecast, by End User; 7.4.5.3 Australia; 7.4.5.3.1 Market size and forecast, by Product; 7.4.5.3.2 Market size and forecast, by Material Type; 7.4.5.3.3 Market size and forecast, by End User; 7.4.5.4 India; 7.4.5.4.1 Market size and forecast, by Product; 7.4.5.4.2 Market size and forecast, by Material Type; 7.4.5.4.3 Market size and forecast, by End User; 7.4.5.5 South Korea; 7.4.5.5.1 Market size and forecast, by Product; 7.4.5.5.2 Market size and forecast, by Material Type; 7.4.5.5.3 Market size and forecast, by End User; 7.4.5.6 Rest of Asia-Pacific; 7.4.5.6.1 Market size and forecast, by Product; 7.4.5.6.2 Market size and forecast, by Material Type; 7.4.5.6.3 Market size and forecast, by End User; 7.5 LAMEA; 7.5.1 Key trends and opportunities; 7.5.2 LAMEA Market size and forecast, by Product; 7.5.3 LAMEA Market size and forecast, by Material Type; 7.5.3.1 LAMEA Metallic Biomaterials Trauma Implants Market by type; 7.5.4 LAMEA Market size and forecast, by End User; 7.5.5 LAMEA Market size and forecast, by country; 7.5.5.1 Brazil; 7.5.5.1.1 Market size and forecast, by Product; 7.5.5.1.2 Market size and forecast, by Material Type; 7.5.5.1.3 Market size and forecast, by End User; 7.5.5.2 Saudi Arabia; 7.5.5.2.1 Market size and forecast, by Product; 7.5.5.2.2 Market size and forecast, by Material Type; 7.5.5.2.3 Market size and forecast, by End User; 7.5.5.3 South Africa; 7.5.5.3.1 Market size and forecast, by Product; 7.5.5.3.2 Market size and forecast, by Material Type; 7.5.5.3.3 Market size and forecast, by End User; 7.5.5.4 Rest of LAMEA; 7.5.5.4.1 Market size and forecast, by Product; 7.5.5.4.2 Market size and forecast, by Material Type; 7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE: 8.1. Introduction; 8.2. Top winning strategies; 8.3. Product Mapping of Top 10 Player; 8.4. Competitive Dashboard; 8.5. Competitive Heatmap; 8.6. Key developments
CHAPTER 9: COMPANY PROFILES: 9.1 Conformis; 9.1.1 Company overview; 9.1.2 Company snapshot; 9.1.3 Operating business segments; 9.1.4 Product portfolio; 9.1.5 Business performance; 9.1.6 Key strategic moves and developments; 9.2 Globus Medical Inc.; 9.2.1 Company overview; 9.2.2 Company snapshot; 9.2.3 Operating business segments; 9.2.4 Product portfolio; 9.2.5 Business performance; 9.2.6 Key strategic moves and developments; 9.3 Johnson & Johnson (Depuy Synthes); 9.3.1 Company overview; 9.3.2 Company snapshot; 9.3.3 Operating business segments; 9.3.4 Product portfolio; 9.3.5 Business performance; 9.3.6 Key strategic moves and developments; 9.4 B. Braun Melsungen Ag; 9.4.1 Company overview; 9.4.2 Company snapshot; 9.4.3 Operating business segments; 9.4.4 Product portfolio; 9.4.5 Business performance; 9.4.6 Key strategic moves and developments; 9.5 Bioretec Ltd,; 9.5.1 Company overview; 9.5.2 Company snapshot; 9.5.3 Operating business segments; 9.5.4 Product portfolio; 9.5.5 Business performance; 9.5.6 Key strategic moves and developments; 9.6 Colson Medical Llc (Acumed); 9.6.1 Company overview; 9.6.2 Company snapshot; 9.6.3 Operating business segments; 9.6.4 Product portfolio; 9.6.5 Business performance; 9.6.6 Key strategic moves and developments; 9.7 Medtronic Plc,; 9.7.1 Company overview; 9.7.2 Company snapshot; 9.7.3 Operating business segments; 9.7.4 Product portfolio; 9.7.5 Business performance; 9.7.6 Key strategic moves and developments; 9.8 Orthofix Medical, Inc; 9.8.1 Company overview; 9.8.2 Company snapshot; 9.8.3 Operating business segments; 9.8.4 Product portfolio; 9.8.5 Business performance; 9.8.6 Key strategic moves and developments; 9.9 Siora Surgicals Pvt. Ltd.; 9.9.1 Company overview; 9.9.2 Company snapshot; 9.9.3 Operating business segments; 9.9.4 Product portfolio; 9.9.5 Business performance; 9.9.6 Key strategic moves and developments; 9.10 Smith & Nephew plc; 9.10.1 Company overview; 9.10.2 Company snapshot; 9.10.3 Operating business segments; 9.10.4 Product portfolio; 9.10.5 Business performance; 9.10.6 Key strategic moves and developments; 9.11 Stryker Corporations; 9.11.1 Company overview; 9.11.2 Company snapshot; 9.11.3 Operating business segments; 9.11.4 Product portfolio; 9.11.5 Business performance; 9.11.6 Key strategic moves and developments; 9.12 Zimmer Biomet Holdings; 9.12.1 Company overview; 9.12.2 Company snapshot; 9.12.3 Operating business segments; 9.12.4 Product portfolio; 9.12.5 Business performance; 9.12.6 Key strategic moves and developments
LIST OF TABLES: TABLE 1. GLOBAL TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 2. TRAUMA IMPLANTS MARKET, FOR SCREWS, BY REGION, 2021-2031 ($MILLION); TABLE 3. TRAUMA IMPLANTS MARKET FOR SCREWS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 4. TRAUMA IMPLANTS MARKET, FOR PLATES, BY REGION, 2021-2031 ($MILLION); TABLE 5. TRAUMA IMPLANTS MARKET FOR PLATES, BY COUNTRY, 2021-2031 ($MILLION); TABLE 6. TRAUMA IMPLANTS MARKET, FOR INTERLOCKING NAILS, BY REGION, 2021-2031 ($MILLION); TABLE 7. TRAUMA IMPLANTS MARKET FOR INTERLOCKING NAILS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 8. TRAUMA IMPLANTS MARKET, FOR BIOABSORBABLE FIXATORS, BY REGION, 2021-2031 ($MILLION); TABLE 9. TRAUMA IMPLANTS MARKET FOR BIOABSORBABLE FIXATORS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 10. TRAUMA IMPLANTS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION); TABLE 11. TRAUMA IMPLANTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 12. GLOBAL TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 13. TRAUMA IMPLANTS MARKET, FOR METALLIC BIOMATERIALS, BY REGION, 2021-2031 ($MILLION); TABLE 14. TRAUMA IMPLANTS MARKET FOR METALLIC BIOMATERIALS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 15. GLOBAL METALLIC BIOMATERIALS TRAUMA IMPLANTS MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 16. TRAUMA IMPLANTS MARKET, FOR STAINLESS STEEL, BY REGION, 2021-2031 ($MILLION); TABLE 17. TRAUMA IMPLANTS MARKET, FOR TITANIUM, BY REGION, 2021-2031 ($MILLION); TABLE 18. TRAUMA IMPLANTS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION); TABLE 19. TRAUMA IMPLANTS MARKET, FOR BIOABSORBABLE MATERIAL, BY REGION, 2021-2031 ($MILLION); TABLE 20. TRAUMA IMPLANTS MARKET FOR BIOABSORBABLE MATERIAL, BY COUNTRY, 2021-2031 ($MILLION); TABLE 21. GLOBAL TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 22. TRAUMA IMPLANTS MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION); TABLE 23. TRAUMA IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 24. TRAUMA IMPLANTS MARKET, FOR ORTHOPEDIC CENTERS, BY REGION, 2021-2031 ($MILLION); TABLE 25. TRAUMA IMPLANTS MARKET FOR ORTHOPEDIC CENTERS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 26. TRAUMA IMPLANTS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION); TABLE 27. TRAUMA IMPLANTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION); TABLE 28. TRAUMA IMPLANTS MARKET, BY REGION, 2021-2031 ($MILLION); TABLE 29. NORTH AMERICA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 30. NORTH AMERICA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 31. NORTH AMERICA METALLIC BIOMATERIALS TRAUMA IMPLANTS MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 32. NORTH AMERICA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 33. NORTH AMERICA TRAUMA IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION); TABLE 34. U.S. TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 35. U.S. TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 36. U.S. TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 37. CANADA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 38. CANADA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 39. CANADA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 40. MEXICO TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 41. MEXICO TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 42. MEXICO TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 43. EUROPE TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 44. EUROPE TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 45. EUROPE METALLIC BIOMATERIALS TRAUMA IMPLANTS MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 46. EUROPE TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 47. EUROPE TRAUMA IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION); TABLE 48. GERMANY TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 49. GERMANY TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 50. GERMANY TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 51. FRANCE TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 52. FRANCE TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 53. FRANCE TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 54. UK TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 55. UK TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 56. UK TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 57. ITALY TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 58. ITALY TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 59. ITALY TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 60. SPAIN TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 61. SPAIN TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 62. SPAIN TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 63. REST OF EUROPE TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 64. REST OF EUROPE TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 65. REST OF EUROPE TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 66. ASIA-PACIFIC TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 67. ASIA-PACIFIC TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 68. ASIA-PACIFIC METALLIC BIOMATERIALS TRAUMA IMPLANTS MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 69. ASIA-PACIFIC TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 70. ASIA-PACIFIC TRAUMA IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION); TABLE 71. JAPAN TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 72. JAPAN TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 73. JAPAN TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 74. CHINA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 75. CHINA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 76. CHINA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 77. AUSTRALIA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 78. AUSTRALIA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 79. AUSTRALIA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 80. INDIA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 81. INDIA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 82. INDIA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 83. SOUTH KOREA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 84. SOUTH KOREA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 85. SOUTH KOREA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 86. REST OF ASIA-PACIFIC TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 87. REST OF ASIA-PACIFIC TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 88. REST OF ASIA-PACIFIC TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 89. LAMEA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 90. LAMEA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 91. LAMEA METALLIC BIOMATERIALS TRAUMA IMPLANTS MARKET, BY TYPE, 2021-2031 ($MILLION); TABLE 92. LAMEA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 93. LAMEA TRAUMA IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION); TABLE 94. BRAZIL TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 95. BRAZIL TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 96. BRAZIL TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 97. SAUDI ARABIA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 98. SAUDI ARABIA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 99. SAUDI ARABIA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 100. SOUTH AFRICA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 101. SOUTH AFRICA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 102. SOUTH AFRICA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 103. REST OF LAMEA TRAUMA IMPLANTS MARKET, BY PRODUCT, 2021-2031 ($MILLION); TABLE 104. REST OF LAMEA TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE, 2021-2031 ($MILLION); TABLE 105. REST OF LAMEA TRAUMA IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION); TABLE 106.CONFORMIS: COMPANY SNAPSHOT; TABLE 107.CONFORMIS: OPERATING SEGMENTS; TABLE 108.CONFORMIS: PRODUCT PORTFOLIO; TABLE 109.CONFORMIS: NET SALES,; TABLE 110.CONFORMIS: KEY STRATERGIES; TABLE 111.GLOBUS MEDICAL INC.: COMPANY SNAPSHOT; TABLE 112.GLOBUS MEDICAL INC.: OPERATING SEGMENTS; TABLE 113.GLOBUS MEDICAL INC.: PRODUCT PORTFOLIO; TABLE 114.GLOBUS MEDICAL INC.: NET SALES,; TABLE 115.GLOBUS MEDICAL INC.: KEY STRATERGIES; TABLE 116.JOHNSON & JOHNSON (DEPUY SYNTHES): COMPANY SNAPSHOT; TABLE 117.JOHNSON & JOHNSON (DEPUY SYNTHES): OPERATING SEGMENTS; TABLE 118.JOHNSON & JOHNSON (DEPUY SYNTHES): PRODUCT PORTFOLIO; TABLE 119.JOHNSON & JOHNSON (DEPUY SYNTHES): NET SALES,; TABLE 120.JOHNSON & JOHNSON (DEPUY SYNTHES): KEY STRATERGIES; TABLE 121.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT; TABLE 122.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS; TABLE 123.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO; TABLE 124.B. BRAUN MELSUNGEN AG: NET SALES,; TABLE 125.B. BRAUN MELSUNGEN AG: KEY STRATERGIES; TABLE 126.BIORETEC LTD,: COMPANY SNAPSHOT; TABLE 127.BIORETEC LTD,: OPERATING SEGMENTS; TABLE 128.BIORETEC LTD,: PRODUCT PORTFOLIO; TABLE 129.BIORETEC LTD,: NET SALES,; TABLE 130.BIORETEC LTD,: KEY STRATERGIES; TABLE 131.COLSON MEDICAL LLC (ACUMED): COMPANY SNAPSHOT; TABLE 132.COLSON MEDICAL LLC (ACUMED): OPERATING SEGMENTS; TABLE 133.COLSON MEDICAL LLC (ACUMED): PRODUCT PORTFOLIO; TABLE 134.COLSON MEDICAL LLC (ACUMED): NET SALES,; TABLE 135.COLSON MEDICAL LLC (ACUMED): KEY STRATERGIES; TABLE 136.MEDTRONIC PLC,: COMPANY SNAPSHOT; TABLE 137.MEDTRONIC PLC,: OPERATING SEGMENTS; TABLE 138.MEDTRONIC PLC,: PRODUCT PORTFOLIO; TABLE 139.MEDTRONIC PLC,: NET SALES,; TABLE 140.MEDTRONIC PLC,: KEY STRATERGIES; TABLE 141.ORTHOFIX MEDICAL, INC: COMPANY SNAPSHOT; TABLE 142.ORTHOFIX MEDICAL, INC: OPERATING SEGMENTS; TABLE 143.ORTHOFIX MEDICAL, INC: PRODUCT PORTFOLIO; TABLE 144.ORTHOFIX MEDICAL, INC: NET SALES,; TABLE 145.ORTHOFIX MEDICAL, INC: KEY STRATERGIES; TABLE 146.SIORA SURGICALS PVT. LTD.: COMPANY SNAPSHOT; TABLE 147.SIORA SURGICALS PVT. LTD.: OPERATING SEGMENTS; TABLE 148.SIORA SURGICALS PVT. LTD.: PRODUCT PORTFOLIO; TABLE 149.SIORA SURGICALS PVT. LTD.: NET SALES,; TABLE 150.SIORA SURGICALS PVT. LTD.: KEY STRATERGIES; TABLE 151.SMITH & NEPHEW PLC: COMPANY SNAPSHOT; TABLE 152.SMITH & NEPHEW PLC: OPERATING SEGMENTS; TABLE 153.SMITH & NEPHEW PLC: PRODUCT PORTFOLIO; TABLE 154.SMITH & NEPHEW PLC: NET SALES,; TABLE 155.SMITH & NEPHEW PLC: KEY STRATERGIES; TABLE 156.STRYKER CORPORATIONS: COMPANY SNAPSHOT; TABLE 157.STRYKER CORPORATIONS: OPERATING SEGMENTS; TABLE 158.STRYKER CORPORATIONS: PRODUCT PORTFOLIO; TABLE 159.STRYKER CORPORATIONS: NET SALES,; TABLE 160.STRYKER CORPORATIONS: KEY STRATERGIES; TABLE 161.ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT; TABLE 162.ZIMMER BIOMET HOLDINGS: OPERATING SEGMENTS; TABLE 163.ZIMMER BIOMET HOLDINGS: PRODUCT PORTFOLIO; TABLE 164.ZIMMER BIOMET HOLDINGS: NET SALES,; TABLE 165.ZIMMER BIOMET HOLDINGS: KEY STRATERGIES
LIST OF FIGURES: FIGURE 1.TRAUMA IMPLANTS MARKET SEGMENTATION; FIGURE 2.TRAUMA IMPLANTS MARKET,2021-2031; FIGURE 3.TRAUMA IMPLANTS MARKET,2021-2031; FIGURE 4. TOP INVESTMENT POCKETS, BY REGION; FIGURE 5.PORTER FIVE-1; FIGURE 6.PORTER FIVE-2; FIGURE 7.PORTER FIVE-3; FIGURE 8.PORTER FIVE-4; FIGURE 9.PORTER FIVE-5; FIGURE 10.TOP PLAYER POSITIONING; FIGURE 11.TRAUMA IMPLANTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES; FIGURE 12.TRAUMA IMPLANTS MARKET,BY PRODUCT,2021(%); FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SCREWS TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 14.COMPARATIVE SHARE ANALYSIS OF PLATES TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 15.COMPARATIVE SHARE ANALYSIS OF INTERLOCKING NAILS TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BIOABSORBABLE FIXATORS TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 18.TRAUMA IMPLANTS MARKET,BY MATERIAL TYPE,2021(%); FIGURE 19.COMPARATIVE SHARE ANALYSIS OF METALLIC BIOMATERIALS TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 20.COMPARATIVE SHARE ANALYSIS OF BIOABSORBABLE MATERIAL TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 21.TRAUMA IMPLANTS MARKET,BY END USER,2021(%); FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITALS TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC CENTERS TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS TRAUMA IMPLANTS MARKET,2021-2031(%); FIGURE 25.TRAUMA IMPLANTS MARKET BY REGION,2021; FIGURE 26.U.S. TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 27.CANADA TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 28.MEXICO TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 29.GERMANY TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 30.FRANCE TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 31.UK TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 32.ITALY TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 33.SPAIN TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 34.REST OF EUROPE TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 35.JAPAN TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 36.CHINA TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 37.AUSTRALIA TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 38.INDIA TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 39.SOUTH KOREA TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 40.REST OF ASIA-PACIFIC TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 41.BRAZIL TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 42.SAUDI ARABIA TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 43.SOUTH AFRICA TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 44.REST OF LAMEA TRAUMA IMPLANTS MARKET,2021-2031($MILLION); FIGURE 45. TOP WINNING STRATEGIES, BY YEAR; FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT; FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY; FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS; FIGURE 49.COMPETITIVE DASHBOARD; FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS; FIGURE 51.CONFORMIS.: NET SALES ,($MILLION); FIGURE 52.GLOBUS MEDICAL INC..: NET SALES ,($MILLION); FIGURE 53.JOHNSON & JOHNSON (DEPUY SYNTHES).: NET SALES ,($MILLION); FIGURE 54.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION); FIGURE 55.BIORETEC LTD,.: NET SALES ,($MILLION); FIGURE 56.COLSON MEDICAL LLC (ACUMED).: NET SALES ,($MILLION); FIGURE 57.MEDTRONIC PLC,.: NET SALES ,($MILLION); FIGURE 58.ORTHOFIX MEDICAL, INC.: NET SALES ,($MILLION); FIGURE 59.SIORA SURGICALS PVT. LTD..: NET SALES ,($MILLION); FIGURE 60.SMITH & NEPHEW PLC.: NET SALES ,($MILLION); FIGURE 61.STRYKER CORPORATIONS.: NET SALES ,($MILLION); FIGURE 62.ZIMMER BIOMET HOLDINGS.: NET SALES ,($MILLION)